Clinical Trial: A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Early Alzheimer's Disease
Study Type: INTERVENTIONAL
Official Title: Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's D
Brief Summary:
This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.
Read more